Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Xianxiang medicine for treating hepatitis B and its production method

A technology of Xianxiang Hepatitis B and a production method, which are applied in directions such as drug combinations, pharmaceutical formulations, plant raw materials, etc., can solve the problems of no ideal antiviral drug for hepatitis B, high cost of hepatitis B treatment, unsatisfactory treatment results and the like.

Inactive Publication Date: 2008-10-01
唐素筠
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no ideal antiviral drug for the treatment of hepatitis B, and the current clinical treatment results of traditional Chinese medicine and modern medicine are also unsatisfactory.
Due to the high cost of hepatitis B treatment, it is also unaffordable for most hepatitis B patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Example 1, the xianxiang hepatitis B drug contains 10 parts of Agrimony, 10 parts of Cynorrhizae, 6 parts of Wild Chrysanthemum, 6 parts of Radix Paeoniae Rubra, and 8 parts of Scutellaria barbata in parts by weight of raw materials.

Embodiment 2

[0017] Example 2, the xianxiang hepatitis B drug contains 20 parts of agrimony, 20 parts of sage, 18 parts of wild chrysanthemum, 18 parts of red peony, and 20 parts of Scutellaria barbata in parts by weight of raw materials.

Embodiment 3

[0018] Example 3, the xianxiang hepatitis B drug contains 10 parts of agrimony, 20 parts of Rhizoma chinensis, 6 parts of wild chrysanthemum, 18 parts of red peony and 8 parts of Scutellaria barbata in parts by weight of raw materials.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for the patients carrying HBV and treating hepatitis B and hepatocirrhosis is prepared from agrimonia herb, elsholtzia herb, wild chrysanthemum flower, red peony root and barbat skullcap. Its preparing process is also disclosed.

Description

technical field [0001] The invention relates to a pharmaceutical composition and a production method thereof, which is a Xianxiang hepatitis B medicine and a production method thereof, and is suitable for treating hepatitis B patients, hepatitis B virus carriers, and patients with early liver cirrhosis of hepatitis B. Background technique [0002] The world's first hepatitis B patient was discovered in Australia in 1963 and introduced to China in the 1970s. In the traditional medicine of the motherland, there is no theory of hepatitis B and the treatment of hepatitis B disease, and hepatitis B can only be classified into the scope of "jaundice", "hypochondriac pain" and "accumulation" according to the syndrome differentiation of traditional Chinese medicine. This disease is mostly caused by the lack of righteousness of the spleen and stomach, the weakening of the body's disease resistance, and the invasion of damp-heat pathogens. The first offender is the spleen and stomach,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/884A61K36/73A61K36/71A61K36/708A61K36/704A61K36/539A61K36/53A61K36/28A61K9/14A61K9/16A61K9/20A61K9/48A61P1/16A61P31/20
Inventor 唐素筠
Owner 唐素筠
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products